G-Quadruplex-Binding Proteins: Promising Targets for Drug Design

Biomolecules. 2022 Apr 29;12(5):648. doi: 10.3390/biom12050648.

Abstract

G-quadruplexes (G4s) are non-canonical secondary nucleic acid structures. Sequences with the potential to form G4s are abundant in regulatory regions of the genome including telomeres, promoters and 5' non-coding regions, indicating they fulfill important genome regulatory functions. Generally, G4s perform various biological functions by interacting with proteins. In recent years, an increasing number of G-quadruplex-binding proteins have been identified with biochemical experiments. G4-binding proteins are involved in vital cellular processes such as telomere maintenance, DNA replication, gene transcription, mRNA processing. Therefore, G4-binding proteins are also associated with various human diseases. An intensive study of G4-protein interactions provides an attractive approach for potential therapeutics and these proteins can be considered as drug targets for novel medical treatment. In this review, we present biological functions and structural properties of G4-binding proteins, and discuss how to exploit G4-protein interactions to develop new therapeutic targets.

Keywords: G-quadruplex; G-quadruplex-binding protein; G4; diseases; drug target; therapeutics.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biophysical Phenomena
  • Drug Design
  • G-Quadruplexes*
  • Humans
  • Promoter Regions, Genetic
  • Telomere

Grants and funding

This research was supported by the National Natural Science Foundation of China (No.61972084 and 62002060) and the Postgraduate Research & Practice Innovation Program of Jiangsu Province (No. KYCX21_0143).